134 related articles for article (PubMed ID: 24393883)
1. [Hepatic arterial infusion chemotherapy with gemcitabine for patients with postoperative liver metastases from pancreatic cancer].
Tajima H; Kitagawa H; Shoji M; Okamoto K; Nakanuma S; Sakai S; Kinoshita J; Makino I; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Miyashita T; Takamura H; Ohta T; Minami T; Koda W; Sanada J; Gabata T; Sai Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1668-71. PubMed ID: 24393883
[TBL] [Abstract][Full Text] [Related]
2. [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].
Iwauchi T; Amano R; Ohira G; Nakamoto K; Doi Y; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2373-5. PubMed ID: 21224577
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil or oral S-1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer.
Tajima H; Kitagawa H; Tsukada T; Okamoto K; Nakanuma SI; Sakai S; Makino I; Furukawa H; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Itoh H; Fujita H; Takamura H; Ninomiya I; Fushida S; Fujimura T; Ohta T; Koda W; Minami T; Ryu Y; Sanada J; Gabata T; Matsui O; Sai Y
Mol Clin Oncol; 2013 Sep; 1(5):869-874. PubMed ID: 24649263
[TBL] [Abstract][Full Text] [Related]
4. [A case of postoperative multiple liver metastases of pancreatic cancer successfully treated by combination chemotherapy with weekly high-dose 5-FU hepatic arterial infusion plus systemic infusion of gemcitabine].
Doh J; Sho M; Tanaka T; Yamada T; Nomi T; Akahori T; Yamato I; Nishiofuku H; Tamamoto T; Hasegawa M; Kichikawa K; Nakajima Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2087-9. PubMed ID: 20037332
[TBL] [Abstract][Full Text] [Related]
5. [A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer].
Nakayama A; Tajima H; Kitagawa H; Shoji M; Nakanuma S; Makino I; Hayashi H; Nakagawara H; Miyashita T; Takamura H; Ohta T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2205-7. PubMed ID: 25731471
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intrahepatic perfusion on fusion imaging using a combined CT/SPECT system: influence of anatomic variations on hemodynamic modification before installation of implantable port systems for hepatic arterial infusion chemotherapy.
Ikeda O; Tamura Y; Nakasone Y; Shiraishi S; Kawanaka K; Tomiguchi S; Takamori H; Chikamoto A; Kanemitsu K; Yamashita Y
Cardiovasc Intervent Radiol; 2007; 30(3):383-91. PubMed ID: 17225972
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of selective continuous transarterial infusion chemotherapy on advanced pancreatic cancer].
Zhou JX; Hong GB; Xu LY; Xu LF; Chen YT; Jiang RJ; Luo JH
Ai Zheng; 2004 Dec; 23(12):1677-80. PubMed ID: 15601559
[TBL] [Abstract][Full Text] [Related]
8. Hepatic artery infusion pump for nasopharyngeal carcinoma with liver metastasis.
Peng C; Zhou C; Li G; Li H; Shi L
Clin Exp Metastasis; 2020 Apr; 37(2):333-339. PubMed ID: 31863241
[TBL] [Abstract][Full Text] [Related]
9. 5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer.
Takamori H; Kanemitsu K; Tsuji T; Tanaka H; Chikamoto A; Nakahara O; Hiraoka T; Ikeda O; Kudo K; Imuta M; Yamashita Y
Pancreas; 2005 Apr; 30(3):223-6. PubMed ID: 15782098
[TBL] [Abstract][Full Text] [Related]
10. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
11. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion chemotherapy reduced hepatic metastases from pancreatic cancer after pancreatectomy.
Zheng YY; Tang CW; Xu YQ; Feng WM; Bao Y; Fei MY
Hepatogastroenterology; 2014; 61(133):1415-20. PubMed ID: 25436319
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for patients with postoperative liver metastases from pancreatic cancer.
Tajima H; Ohta T; Kitagawa H; Sakai S; Makino I; Hayashi H; Oyama K; Nakagawara H; Fujita H; Onishi I; Takamura H; Ninomiya I; Fushida S; Tani T; Fujimura T; Koda W; Minami T; Ryu Y; Sanada J; Gabata T; Matsui O
Exp Ther Med; 2011 Mar; 2(2):265-269. PubMed ID: 22977495
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
Sato Y; Tsuchiya Y; Aizawa M; Nomura T; Nashimoto A
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1151-4. PubMed ID: 25248901
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
[TBL] [Abstract][Full Text] [Related]
16. Successful management of multiple liver metastases from pancreatic neuroendocrine tumor by hepatic arterial administration of cisplatin powder.
Igarashi H; Ito T; Yoshinaga M; Kodama M; Hayashi H; Sakai H; Kawabe K; Takayanagi R
Pancreas; 2007 Oct; 35(3):288-90. PubMed ID: 17895855
[No Abstract] [Full Text] [Related]
17. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
Lorenz M; Müller HH
J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
[TBL] [Abstract][Full Text] [Related]
18. [Nab-Paclitaxel plus Gemcitabine for Metastatic Pancreatic Cancer].
Katsura Y; Takeda Y; Ohmura Y; Motoyama Y; Ishida T; Morimoto Y; Matsushita K; Naito A; Murakami K; Kagawa Y; Okishiro M; Takeno A; Egawa C; Kato T; Tamura S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2367-9. PubMed ID: 26805366
[TBL] [Abstract][Full Text] [Related]
19. Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.
Ottaiano A; Capozzi M; DE Divitiis C; VON Arx C; DI Girolamo E; Nasti G; Cavalcanti E; Tatangelo F; Romano G; Avallone A; Tafuto S
Anticancer Res; 2017 Apr; 37(4):1975-1978. PubMed ID: 28373469
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.
Cahan B; Leong L; Wagman L; Yamauchi D; Shibata S; Wilzcynski S; Williams LE; Yazaki P; Colcher D; Frankel P; Wu A; Raubitschek A; Shively J; Wong JYC
Cancer Biother Radiopharm; 2017 Sep; 32(7):258-265. PubMed ID: 28910150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
